BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12795445)

  • 1. Emerging evidence on the role of soy in reducing prostate cancer risk.
    Messina MJ
    Nutr Rev; 2003 Apr; 61(4):117-31. PubMed ID: 12795445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.
    Messina M; Bennink M
    Baillieres Clin Endocrinol Metab; 1998 Dec; 12(4):707-28. PubMed ID: 10384821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
    Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
    Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy intake and cancer risk: a review of the in vitro and in vivo data.
    Messina MJ; Persky V; Setchell KD; Barnes S
    Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
    Mahmoud AM; Yang W; Bosland MC
    J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legumes and soybeans: overview of their nutritional profiles and health effects.
    Messina MJ
    Am J Clin Nutr; 1999 Sep; 70(3 Suppl):439S-450S. PubMed ID: 10479216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
    Dong X; Xu W; Sikes RA; Wu C
    Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
    Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
    Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specific role of isoflavones in reducing prostate cancer risk.
    Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
    Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats.
    Onozawa M; Kawamori T; Baba M; Fukuda K; Toda T; Sato H; Ohtani M; Akaza H; Sugimura T; Wakabayashi K
    Jpn J Cancer Res; 1999 Apr; 90(4):393-8. PubMed ID: 10363576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy, isoflavones, and prostate cancer.
    Jian L
    Mol Nutr Food Res; 2009 Feb; 53(2):217-26. PubMed ID: 18985655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP.
    Onozawa M; Fukuda K; Ohtani M; Akaza H; Sugimura T; Wakabayashi K
    Jpn J Clin Oncol; 1998 Jun; 28(6):360-3. PubMed ID: 9730149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy, disease prevention, and prostate cancer.
    Moyad MA
    Semin Urol Oncol; 1999 May; 17(2):97-102. PubMed ID: 10332923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.
    Ahmad IU; Forman JD; Sarkar FH; Hillman GG; Heath E; Vaishampayan U; Cher ML; Andic F; Rossi PJ; Kucuk O
    Nutr Cancer; 2010; 62(7):996-1000. PubMed ID: 20924975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
    Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
    J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition and prostate cancer: a review.
    Cohen LA
    Ann N Y Acad Sci; 2002 Jun; 963():148-55. PubMed ID: 12095940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.